Evidence map›Paper›PMID 39624211›Full record

ArticleStem cells international2024

Identification of a Novel Mesenchymal Stem Cell-Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer.

Enguang Yang, Luhua Ji, Xinyu Zhang, Suoshi Jing, Pan Li, Hanzhang Wang, Luyang Zhang, Yuanfeng Zhang, Li Yang, Junqiang Tian and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Enguang Yang *Institute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.ORCID https://orcid.org/0000-0002-9028-8065
Luhua Ji *Institute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Xinyu Zhang *Institute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Suoshi JingInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Pan LiInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Hanzhang WangDepartment of Pathology and Laboratory Medicine, Legorreta Cancer Center at Brown University, The Warren Alpert Medical School of Brown University, Brown University Health, Providence 02912, Rhode Island, USA.ORCID https://orcid.org/0000-0002-8370-2061
Luyang ZhangInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Yuanfeng ZhangInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.ORCID https://orcid.org/0000-0002-4330-072X
Li YangInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Junqiang TianInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
Zhiping WangInstitute of Urology, Key Laboratory of Gansu Province for Urological Diseases, Gansu Urological Clinical Center, Lanzhou University Second Hospital, Lanzhou 730030, China.ORCID https://orcid.org/0000-0002-8140-591X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

mesenchymal stem celltumor microenvironmenturinary bladderurothelial carcinoma

Identifiers

PMID39624211
PMCPMC11611448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.